A lightweight, granular, dressing compound developed and studied by Virginia Commonwealth University researchers that quickly stems high-pressure bleeding in moderate to severe wounds has received FDA approval and will soon be used in combat. Read more.
« VCU Across the Spectrum launches in December | Main | VCU on research team receiving NIH grant to shed light on standards of scientific conduct »